Skip to main content

Table 3 Patient characteristics associated with statin and ACEI/ARB prescribing at in-person office visits at 10 community health centers in Oregon where the medication(s) was/were clinically indicateda, June 2011 to May 2014

From: Cardiovascular care guideline implementation in community health centers in Oregon: a mixed-methods analysis of real-world barriers and challenges

 

Office visitsb where a statin indicated

Office visitsb where an ACEI/ARB was indicated

Number of encountersc

% with an statin Rx < = 2 days

p-value

Number of encountersc

% with an ACEI/ARBs Rx < = 2 days

p-value

Total

11588

(13.2)

 

9887

(15.8)

 

Patient characteristics

 Sex

  

<.0001

  

<.0001

  Male

4198

(15.7)

 

3819

(17.9)

 

  Female

7390

(11.8)

 

6068

(14.5)

 

 Age

  

<.0001

  

0.0607

  18–39

1582

(12.2)

 

747

(17.9)

 

  40–54

3060

(15.5)

 

2473

(16.7)

 

  55–75

6946

(12.5)

 

6667

(15.3)

 

 Race/ethnicity

  

<.0001

  

<.0001

  Hispanic

3721

(17.7)

 

2714

(22.2)

 

  Non-Hispanic White

5460

(10.8)

 

5035

(12.5)

 

  Non-Hispanic Other

2298

(11.7)

 

2032

(15.4)

 

  Missing/Unknown

109

(13.8)

 

106

(20.8)

 

 Language

  

<.0001

  

<.0001

  English

6918

(10.7)

 

6016

(13.0)

 

  Spanish

3303

(18.3)

 

2401

(23.1)

 

  Other

1321

(13.6)

 

1435

(15.4)

 

  Missing/Unknown

46

(10.9)

 

35

(20.0)

 

 % of Federal Poverty Level at encounter

  

0.0293

  

0.2398

   < 100%

8568

(12.9)

 

7294

(15.5)

 

  100–199%

2177

(13.1)

 

1888

(16.3)

 

   > = 200%

751

(16.8)

 

639

(17.8)

 

  Missing/Unknown

92

(12.0)

 

66

(21.2)

 

 Insurance at encounter

  

<.0001

  

<.0001

  Uninsured

3817

(18.2)

 

2542

(26.1)

 

  Insured

7759

(10.8)

 

7330

(12.3)

 

  Missing/Unknown

12

-

 

15

-

 

 Patient smoking status

  

0.042

  

<.0001

  Not current smoker

8917

(13.6)

 

7448

(16.7)

 

  Current smoker

2631

(11.8)

 

2403

(12.6)

 

  Missing/Unknown

40

(17.5)

 

36

(47.2)

 

 Patient has active diagnosis of CVD

  

0.0015

  

<.0001

  No CVD

9984

(13.6)

 

7813

(17.6)

 

  Has CVD

1604

(10.7)

 

2074

(9.2)

 

 Patient has active diagnosis of HTN

  

0.1494

  

0.3498

  No HTN

5316

(13.7)

 

4026

(15.4)

 

  Has HTN

6272

(12.8)

 

5861

(16.1)

 

 Patient has active diagnosis of liver disease

  

<.0001

  

<.0001

  No liver disease

9946

(13.9)

 

8572

(16.5)

 

  Has liver disease

1642

(9.1)

 

1315

(11.3)

 

 Patient has active diagnosis of kidney disease

  

<.0001

  

<.0001

  No kidney disease

10759

(13.6)

 

8614

(17.3)

 

  Has kidney disease

829

(8.1)

 

1273

(6.3)

 

 BMI

  

0.2842

  

0.0009

   < 25

1266

(13.8)

 

1333

(12.5)

 

   > = 25

9914

(13.2)

 

8251

(16.3)

 

  Missing/Unknown

408

(10.8)

 

303

(18.8)

 

 BP control

  

0.1188

  

<.0001

   < 120/80

3174

(12.4)

 

2834

(9.4)

 

  120/80 to 139/89

6375

(13.1)

 

5291

(15.2)

 

  140/90 to 159/99

1702

(14.7)

 

1459

(26.6)

 

   > = 160/100

334

(15.3)

 

301

(35.5)

 

  Missing/Unknown

3

(33.3)

 

2

-

 

 HbA1c control

  

<.0001

  

<.0001

   < 7

5115

(10.3)

 

4398

(12.8)

 

   > = 7

6197

(15.7)

 

5192

(18.4)

 

  Missing/Unknown

276

(11.6)

 

297

(16.5)

 

 LDL control

  

<.0001

  

<.0001

   < =100 or missing

4744

(9.6)

 

5867

(14.3)

 

  100 to 129

4163

(13.7)

 

2194

(18.0)

 

  > = 130

2681

(18.9)

 

1826

(18.1)

 
  1. Abbreviations: ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blockers, BMI Body Mass Index; BP blood pressure, CVD cardiovascular disease, HbA1c glycated hemoglobin, HTN hypertension, LDL-low-density lipoproteins, Rx prescription
  2. aPoint-of-care alert for specified drug class fired at the visit
  3. bOffice visits defined as in-person encounters at a study clinic where the provider was a MD, PA, NP, or resident, and the encounter Evaluation & Management CPT code was in: 99201-99205; 99212-99215; 99243; 99385-99387; 99395-99397
  4. cVisit counts are not mutually exclusive, e.g., if both types of BPA fired at a visit, the visit is counted in both the statin and ACEI/ARB columns. p-value from chi square test for independence between characteristic and outcome of Rx < = 2 days